Truist slashes price target on Bausch Health Companies Inc. [BHC] – find out why.

Bausch Health Companies Inc. [NYSE: BHC] gained 0.62% or 0.04 points to close at $6.49 with a heavy trading volume of 6448608 shares. The company report on September 2, 2022 that S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


As a result of the quarterly review, S&P Dow Jones Indices will make the following changes in the S&P/TSX Composite Index and S&P/TSX 60 Index prior to the open of trading on Monday, September 19, 2022:.

It opened the trading session at $6.48, the shares rose to $6.57 and dropped to $6.21, the range by which the price of stock traded the whole day. The daily chart for BHC points out that the company has recorded -70.17% loss over the past six months. However, it is still -62.25% lower than its most recent low trading price.

If we look at the average trading volume of 7.77M shares, BHC reached to a volume of 6448608 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Bausch Health Companies Inc. [BHC]:

Truist have made an estimate for Bausch Health Companies Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on July 29, 2022. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price from $12 to $5. The new note on the price target was released on July 29, 2022, representing the official price target for Bausch Health Companies Inc. stock.

The Average True Range (ATR) for Bausch Health Companies Inc. is set at 0.62, with the Price to Sales ratio for BHC stock in the period of the last 12 months amounting to 0.29. Price to Free Cash Flow for BHC in the course of the last twelve months was 5.88 with Quick ratio for the last quarter at 0.90.

Trading performance analysis for BHC stock

Bausch Health Companies Inc. [BHC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.01. With this latest performance, BHC shares gained by 16.10% in over the last four-week period, additionally sinking by -70.17% over the last 6 months – not to mention a drop of -77.87% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHC stock in for the last two-week period is set at 54.36, with the RSI for the last a single of trading hit 62.04, and the three-weeks RSI is set at 49.20 for Bausch Health Companies Inc. [BHC]. The present Moving Average for the last 50 days of trading for this stock 6.98, while it was recorded at 6.12 for the last single week of trading, and 17.33 for the last 200 days.

Bausch Health Companies Inc. [BHC]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Bausch Health Companies Inc. [BHC] shares currently have an operating margin of +18.69 and a Gross Margin at +55.31. Bausch Health Companies Inc.’s Net Margin is presently recorded at -11.24.

Return on Equity for this stock declined to -441.96, with Return on Assets sitting at -3.14.

Bausch Health Companies Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.90 and a Current Ratio set at 1.10.

Bausch Health Companies Inc. [BHC]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BHC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bausch Health Companies Inc. go to 8.70%.

An analysis of insider ownership at Bausch Health Companies Inc. [BHC]

There are presently around $1,586 million, or 66.80% of BHC stock, in the hands of institutional investors. The top three institutional holders of BHC stocks are: ICAHN CARL C with ownership of 34,721,118, which is approximately 0% of the company’s market cap and around 2.30% of the total institutional ownership; PAULSON & CO. INC., holding 26,439,035 shares of the stock with an approximate value of $171.59 million in BHC stocks shares; and VALUEACT HOLDINGS, L.P., currently with $93.08 million in BHC stock with ownership of nearly -0.621% of the company’s market capitalization.

157 institutional holders increased their position in Bausch Health Companies Inc. [NYSE:BHC] by around 43,550,091 shares. Additionally, 197 investors decreased positions by around 57,800,129 shares, while 66 investors held positions by with 143,029,417 shares. The mentioned changes placed institutional holdings at 244,379,637 shares, according to the latest SEC report filing. BHC stock had 47 new institutional investments in for a total of 5,773,250 shares, while 94 institutional investors sold positions of 32,277,328 shares during the same period.


Please enter your comment!
Please enter your name here